U.S. federal trademark · Serial No. 86423216
Scientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
Providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses to immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.